Laurus Labs Limited (LAURUSLABS.NS) Q1 2024 Earnings Report

In Q1 2024, Laurus Labs Limited reported a revenue of ₹11,949 Crores, reflecting a marginal year-over-year growth of 1.1% but a significant drop of 17% compared to the previous quarter. Net income witnessed a more drastic decline, plunging 49.66% on a year-over-year basis and down 83.45% from Q4 2023, with earnings per share also decreasing by 50%. The operating income fell sharply by 18.34% year-over-year and a staggering 53.22% quarter-over-quarter, highlighting substantial operational challenges.

Management highlighted that the decline in revenue stems largely from competitive pressures and pricing pressures in the ARV (antiretroviral) segment, coupled with increased research and development expenditures. Moving forward, the company aims to enhance product offerings and focus on operational efficiencies to stabilize margins and enhance profitability during the remainder of the fiscal year.